K

Karex Bhd
KLSE:KAREX

Watchlist Manager
Karex Bhd
KLSE:KAREX
Watchlist
Price: 0.915 MYR -0.54%
Market Cap: 963.9m MYR
Have any thoughts about
Karex Bhd?
Write Note

Karex Bhd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Karex Bhd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
K
Karex Bhd
KLSE:KAREX
Cash & Cash Equivalents
myr45.1m
CAGR 3-Years
1%
CAGR 5-Years
-5%
CAGR 10-Years
-6%
D
Dswiss Inc
OTC:DQWS
Cash & Cash Equivalents
$473.3k
CAGR 3-Years
33%
CAGR 5-Years
64%
CAGR 10-Years
N/A
E
Eng Kah Corporation Bhd
KLSE:ENGKAH
Cash & Cash Equivalents
myr18.9m
CAGR 3-Years
6%
CAGR 5-Years
-3%
CAGR 10-Years
4%
S
Sunzen Biotech Bhd
KLSE:SUNZEN
Cash & Cash Equivalents
myr21.5m
CAGR 3-Years
-7%
CAGR 5-Years
11%
CAGR 10-Years
15%
B
Bioalpha Holdings Bhd
KLSE:BIOHLDG
Cash & Cash Equivalents
myr7.6m
CAGR 3-Years
-31%
CAGR 5-Years
36%
CAGR 10-Years
N/A
No Stocks Found

Karex Bhd
Glance View

Market Cap
963.9m MYR
Industry
Consumer products

Karex Bhd.is an investment holding company, which engages in the manufacture and sale of sexual wellness, medical, and health related products. The company is headquartered in Klang, Selangor. The company went IPO on 2013-11-06. The Company’s principal business activities include investment holding, manufacture and sale of condoms, latex probe covers, sterile catheters and other rubber products. The Company’s segments include Sexual Wellness and Medical. Its Sexual Wellness segment is engaged in sale of condoms, personal lubricants and sex toys. Its Medical segment is engaged in sale of catheters, probe covers, HIV and pregnancy test kits and other medical related products. These activities are principally located in Malaysia, Thailand, United States of America and Europe. The firm's products include condoms, lubrication jelly, probe cover and foley balloon catheter. The lubrication jelly is greaseless, non-toxic and water soluble, and is suitable for gynecological use or when additional vaginal lubrication is needed. The probe cover product is specially designed for flexibility and safety during intracavity examinations with ultrasound.

KAREX Intrinsic Value
1.073 MYR
Undervaluation 15%
Intrinsic Value
Price
K

See Also

What is Karex Bhd's Cash & Cash Equivalents?
Cash & Cash Equivalents
45.1m MYR

Based on the financial report for Sep 30, 2024, Karex Bhd's Cash & Cash Equivalents amounts to 45.1m MYR.

What is Karex Bhd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-6%

Over the last year, the Cash & Cash Equivalents growth was -2%. The average annual Cash & Cash Equivalents growth rates for Karex Bhd have been 1% over the past three years , -5% over the past five years , and -6% over the past ten years .

Back to Top